These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Separation of central effects of CO2 and nicotine on ventilation and blood pressure. McCarthy LE; Borison HL Respir Physiol; 1972 Jul; 15(3):321-30. PubMed ID: 5050472 [No Abstract] [Full Text] [Related]
27. [Comparative activity of different analeptics against morphine-induced respiratory depression in rabbits]. BARGETON D; KRUMM-HELLER C; EON M Arch Int Pharmacodyn Ther; 1955 Oct; 103(2-3):146-59. PubMed ID: 13259727 [No Abstract] [Full Text] [Related]
28. Hypoxia and carbon dioxide as separate and interactive depressants of ventilation. Ou LC; Tenney SM Respir Physiol; 1976 Dec; 28(3):347-58. PubMed ID: 1019431 [TBL] [Abstract][Full Text] [Related]
29. Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. Sarton E; Teppema L; Dahan A Anesthesiology; 1999 May; 90(5):1329-38. PubMed ID: 10319781 [TBL] [Abstract][Full Text] [Related]
30. Respiratory-stimulating effect of doxapram hydrochloride in drug-induced respiratory depression. Li WK; Revero J; Holder BS Anesth Analg; 1967; 46(5):614-7. PubMed ID: 4383212 [No Abstract] [Full Text] [Related]
31. Almitrine bismesylate and the central and peripheral ventilatory response to CO2. Olievier CN; Berkenbosch A; Degoede J; Kruyt EW J Appl Physiol (1985); 1987 Jul; 63(1):66-74. PubMed ID: 2887541 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacological properties of aminoenanthylic acid]. Gofman SM Farmakol Toksikol; 1968; 31(2):188-9. PubMed ID: 4386316 [No Abstract] [Full Text] [Related]
33. [Contribution of genetic and individually acquired factors in morphine sensitivity in WAG/G and Fischer-344 rats]. Liupina IuV; Medvedeva OF; Tiurina IV; Sudakov SK Biull Eksp Biol Med; 1998 May; 125(5):535-8. PubMed ID: 9644552 [No Abstract] [Full Text] [Related]
34. The effect of drugs on respiration in man. Keats AS Annu Rev Pharmacol Toxicol; 1985; 25():41-65. PubMed ID: 2860846 [No Abstract] [Full Text] [Related]
35. [Analeptic cardiorespiratory properties of the combination of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine-gluconate and heptaminol chlorhydrate]. La Barre J Arzneimittelforschung; 1970 Apr; 20(4):515-9. PubMed ID: 4392907 [No Abstract] [Full Text] [Related]
36. [Drug activity as a function of the experimental pathological state]. Quevauviller A Actual Pharmacol (Paris); 1967; 20():133-67. PubMed ID: 4388945 [No Abstract] [Full Text] [Related]
37. Time course of changes in breathing pattern in morphine- and oxycodone-induced respiratory depression. Leino K; Mildh L; Lertola K; Seppälä T; Kirvelä O Anaesthesia; 1999 Sep; 54(9):835-40. PubMed ID: 10460553 [TBL] [Abstract][Full Text] [Related]
38. The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. 3. Analysis of the central and peripheric effects. Knoll J; Fürst S; Mészáros Z Arzneimittelforschung; 1971 May; 21(5):727-33. PubMed ID: 4998916 [No Abstract] [Full Text] [Related]
39. Sufentanil-induced respiratory depression in dogs. Tadoori P; Ravella R; Silverstein JH; Gintautas J; Abadir AR Prog Clin Biol Res; 1990; 328():393-6. PubMed ID: 1968269 [No Abstract] [Full Text] [Related]
40. Brain amines and development of acute tolerance to and dependence on morphine in the respiratory center of decerebrate cats. Flórez J; Delgado G; Armijo JA Neuropharmacology; 1973 Apr; 12(4):355-62. PubMed ID: 4267389 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]